• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Inferring Amoxicillin-Clavulanate Susceptibility From Ampicillin-Sulbactam Susceptibility Against Common Enterobacterales Species.从氨苄西林-舒巴坦对常见肠杆菌科细菌的敏感性推断阿莫西林-克拉维酸的敏感性
Open Forum Infect Dis. 2025 May 14;12(6):ofaf295. doi: 10.1093/ofid/ofaf295. eCollection 2025 Jun.
2
Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different beta-lactam resistance phenotypes.对具有不同β-内酰胺耐药表型的大肠埃希菌分离株进行氨苄西林-舒巴坦和阿莫西林-克拉维酸药敏试验。
Antimicrob Agents Chemother. 1999 Apr;43(4):862-7. doi: 10.1128/AAC.43.4.862.
3
Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases.阿莫西林-克拉维酸、氨苄西林-舒巴坦和哌拉西林-他唑巴坦对携带已知β-内酰胺酶的大肠杆菌和奇异变形杆菌菌株的体外比较活性。
Infection. 1991 Mar-Apr;19(2):106-9. doi: 10.1007/BF01645578.
4
In vitro activity of ampicillin, amoxicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid against consecutive clinical isolates of Enterobacteriaceae.
Diagn Microbiol Infect Dis. 1993 Aug-Sep;17(2):171-5. doi: 10.1016/0732-8893(93)90030-b.
5
Correlation of in vitro susceptibility testing results for amoxicillin-clavulanate and ampicillin-sulbactam using a panel of beta-lactamase-producing Enterobacteriaceae.使用一组产β-内酰胺酶的肠杆菌科细菌对阿莫西林-克拉维酸和氨苄西林-舒巴坦进行体外药敏试验结果的相关性
APMIS. 1998 Sep;106(9):917-20.
6
Optimal dilution susceptibility testing conditions, recommendations for MIC interpretation, and quality control guidelines for the ampicillin-sulbactam combination.氨苄西林-舒巴坦组合的最佳稀释药敏试验条件、MIC解释建议及质量控制指南。
J Clin Microbiol. 1987 Oct;25(10):1920-5. doi: 10.1128/jcm.25.10.1920-1925.1987.
7
Establishing breakpoints for amoxicillin/clavulanate and ampicillin/sulbactam for rapid antimicrobial susceptibility testing directly from positive blood culture bottles.建立阿莫西林/克拉维酸和氨苄西林/舒巴坦的折点，以便直接从阳性血培养瓶中进行快速抗菌药物敏感性测试。
J Med Microbiol. 2023 Mar;72(3). doi: 10.1099/jmm.0.001672.
8
Correlation of in vitro susceptibility results for amoxicillin-clavulanate and ampicillin-sulbactam tested against Escherichia coli.阿莫西林-克拉维酸与氨苄西林-舒巴坦对大肠杆菌体外药敏试验结果的相关性
J Clin Microbiol. 1997 Jul;35(7):1902-3. doi: 10.1128/jcm.35.7.1902-1903.1997.
9
Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin.β-内酰胺酶抑制剂YTR 830、克拉维酸钠和舒巴坦与阿莫西林或氨苄西林联合使用的比较活性。
Antimicrob Agents Chemother. 1984 Oct;26(4):580-2. doi: 10.1128/AAC.26.4.580.
10
[Errors of the agar diffusion method to predict Escherichia coli's susceptibility to ampicillin-sulbactam and amoxicillin-clavulanic acid].[琼脂扩散法预测大肠埃希菌对氨苄西林-舒巴坦和阿莫西林-克拉维酸敏感性的误差]
Enferm Infecc Microbiol Clin. 1996 May;14(5):308-10.

本文引用的文献

1
Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute.阿莫西林-克拉维酸对肠杆菌科的折点：临床和实验室标准研究所修订的理由。
Clin Infect Dis. 2024 Aug 16;79(2):516-523. doi: 10.1093/cid/ciae201.
2
Transition to Oral Antibiotic Therapy for Hospitalized Adults With Gram-Negative Bloodstream Infections.革兰氏阴性菌血流感染住院成人患者的口服抗生素治疗转换。
JAMA Netw Open. 2024 Jan 2;7(1):e2349864. doi: 10.1001/jamanetworkopen.2023.49864.
3
Classification for β-lactamases: historical perspectives.β-内酰胺酶分类：历史视角。
Expert Rev Anti Infect Ther. 2023 May;21(5):513-522. doi: 10.1080/14787210.2023.2194633. Epub 2023 Apr 6.
4
Comparative Effectiveness and Harms of Antibiotics for Outpatient Diverticulitis : Two Nationwide Cohort Studies.门诊憩室炎抗生素治疗的疗效和危害比较：两项全国性队列研究。
Ann Intern Med. 2021 Jun;174(6):737-746. doi: 10.7326/M20-6315. Epub 2021 Feb 23.
5
Assessing the association between fluoroquinolones and emerging adverse drug reactions raised by regulatory agencies: An umbrella review.评估监管机构提出的氟喹诺酮类药物与新出现的药物不良反应之间的关联：伞式评价。
Eur J Intern Med. 2020 May;75:60-70. doi: 10.1016/j.ejim.2020.01.009. Epub 2020 Jan 23.
6
Oral amoxicillin and amoxicillin-clavulanic acid: properties, indications and usage.口服阿莫西林和阿莫西林克拉维酸：性质、适应证和用途。
Clin Microbiol Infect. 2020 Jul;26(7):871-879. doi: 10.1016/j.cmi.2019.11.028. Epub 2019 Dec 4.
7
Association Between Peripheral Neuropathy and Exposure to Oral Fluoroquinolone or Amoxicillin-Clavulanate Therapy.外周神经病变与口服氟喹诺酮类或阿莫西林克拉维酸暴露的相关性研究。
JAMA Neurol. 2019 Jul 1;76(7):827-833. doi: 10.1001/jamaneurol.2019.0887.
8
Association of Adverse Events With Antibiotic Use in Hospitalized Patients.住院患者不良事件与抗生素使用的关联
JAMA Intern Med. 2017 Sep 1;177(9):1308-1315. doi: 10.1001/jamainternmed.2017.1938.
9
Why the extended-spectrum beta-lactamases SHV-2 and SHV-5 are "hypersusceptible" to mechanism-based inhibitors.为何超广谱β-内酰胺酶SHV-2和SHV-5对基于机制的抑制剂“高度敏感”。
Biochemistry. 2009 Oct 20;48(41):9912-20. doi: 10.1021/bi9012098.
10
The spread of CTX-M-type extended-spectrum beta-lactamases.CTX-M型超广谱β-内酰胺酶的传播
Clin Microbiol Infect. 2008 Jan;14 Suppl 1:33-41. doi: 10.1111/j.1469-0691.2007.01867.x.

Inferring Amoxicillin-Clavulanate Susceptibility From Ampicillin-Sulbactam Susceptibility Against Common Enterobacterales Species.

作者信息

Claeys Kimberly C, Simner Patricia J, Tekle Tsigereda, Harris Anthony D, Cosgrove Sara E, Tamma Pranita D

机构信息

Department of Pharmacy Science and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

出版信息

Open Forum Infect Dis. 2025 May 14;12(6):ofaf295. doi: 10.1093/ofid/ofaf295. eCollection 2025 Jun.

DOI:10.1093/ofid/ofaf295
PMID:40453876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12125676/
Abstract
摘要